Neuren Pharmaceuticals | NEU - Zinsaufwendungen Für Schuld

Aktienkurs
11.76
Täglich Wechseln
-0.19 -1.59%
Monatlich
-8.84%
Jährlich
0.68%
Q1 Prognose
12.09




Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 364.15M 18.56M 2025-09
Alaunos Therapeutics USD 0 0 2023-12
Avita Medical AUD 1.25M 100K 2025-06
Clinuvel Pharmaceuticals AUD 2.43M 414.48K 2024-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Genetic Signatures AUD 18K 17K 2024-06
Ionis Pharmaceuticals USD 18M 0 2025-12
Medical Developments International AUD 18K 3K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organon & Co USD 128M 3M 2025-09
Paradigm Biopharmaceuticals AUD 1000 3K 2025-06
PYC Therapeutics AUD 17K 11K 2025-06
Tectonic Therapeutic USD 277M 276.98M 2025-09
Telix Pharmaceuticals AUD 7.62M 11.22M 2025-12
Viatris USD 119.6M 0 2025-12
Xeris Pharmaceuticals USD 7.27M 92K 2025-09